Telmisartan vs. enalapril in type 2 diabetes
- PMID: 15728820
- DOI: 10.1056/NEJM200502243520819
Telmisartan vs. enalapril in type 2 diabetes
Comment on
-
Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.N Engl J Med. 2004 Nov 4;351(19):1952-61. doi: 10.1056/NEJMoa042274. Epub 2004 Oct 31. N Engl J Med. 2004. PMID: 15516696 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical